Katherine M. Clark Periodic Transaction Report

Filed Apr 4, 2024 · House Clerk · 2 transactions

U.S. Representative · D · MA-05 · All trades by Katherine M. Clark

On April 4, 2024, Rep. Katherine M. Clark (D-MA-05) filed a periodic transaction report with the House Clerk disclosing 2 transactions (2 sales) dated Mar 1, 2024.

The filing covers 1 ticker, including $NYCB.

Reported amount ranges sum to $2K–$30K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 34 days.

Source document: House Clerk filing 20024795

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Katherine M. Clark · Sold $NYCB · Mar 1 · $1K–$15K

0.29LOW

Disclosure speedx 0.250.10

Trade sizex 0.250.20

Cluster activityx 0.150.00

Track recordx 0.350.61

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Katherine M. Clark

Get an email the moment Katherine M. Clark files the next one. Free, no card, no spam.

Follow free →

Transactions

0 / 2

Buys / sells

Tickers

34d

Longest lag

Tickers in this filing

NYCB2

Transactions disclosed

Trade date	Ticker	Asset	Type	Owner	Amount	Lag
Mar 1, 2024	NYCB	New York Community Bancorp, Inc. Common Stock (NYCB)	sell	—	$1K–$15K	34d
Mar 1, 2024	NYCB	New York Community Bancorp, Inc. Common Stock (NYCB)	sell	Self	$1K–$15K	34d

Other recent filings by Katherine M. Clark

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →